cV4 Diagnostic Ultrasound System vs Tempus ECG-AF
AI Verdict
Choose cV4 Diagnostic Ultrasound System if…
Choose the Samsung Medison cV4 Diagnostic Ultrasound System if your clinical setting requires a versatile, AI-enhanced imaging solution for real-time diagnostic visualization across multiple specialties, including OB/GYN, maternal-fetal medicine, and general radiology. This system is ideal for clinicians who need advanced image quality and AI-powered assistance for tasks such as automated fetal heart assessment, biometric measurements, or real-time nerve detection during live examinations.
View cV4 Diagnostic Ultrasound System →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your healthcare facility aims to proactively identify patients aged 65 or older at increased risk of developing atrial fibrillation (AF) within the next 12 months, leveraging existing 12-lead ECG data. This AI-based algorithm is best suited for cardiology, geriatrics, or internal medicine practices focused on early risk stratification and intervention for AF in a defined patient demographic without a prior AF diagnosis.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | cV4 Diagnostic Ultrasound System | Tempus ECG-AF |
|---|---|---|
| Pricing | Unknown | Contact vendor |
| Deployment | On-premise | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
cV4 Diagnostic Ultrasound SystemTool A, the cV4 Diagnostic Ultrasound System, integrates AI directly into the imaging workflow with features like HeartAssist and BiometryAssist, aiming to streamline real-time tasks for the operator. Its fanless design also contributes to a quieter and potentially more comfortable user experience. Tool B is a software algorithm that provides an analysis result, requiring interpretation within a broader clinical context.
Clinical Value
Tempus ECG-AFTool B, Tempus ECG-AF, offers significant clinical value by identifying patients at increased risk of developing atrial fibrillation/flutter within 12 months, enabling earlier intervention and potentially preventing serious complications. While Tool A enhances real-time diagnostic accuracy across multiple specialties, Tool B's focus on predictive risk stratification for a prevalent and high-impact cardiovascular condition provides a distinct preventative health advantage.
Pricing & Value
Tempus ECG-AFTool B, Tempus ECG-AF, has a clear and established CMS reimbursement pathway (CPT 0764T and CPT 0765T with a Medicare rate of $128.90), making its financial value proposition transparent and easier for healthcare providers to justify. Tool A, being a capital equipment purchase, has less transparent pricing that varies by configuration and regional agreements, requiring a larger upfront investment.
Enterprise Readiness
Tempus ECG-AFBoth tools are HIPAA compliant and FDA cleared. However, Tool B explicitly states it is a 'software solution, integrated into healthcare facility systems' and 'has BAA', which are critical for seamless enterprise adoption and compliance for software. While Tool A offers robust data security and DICOM compatibility, the explicit mention of integration and a Business Associate Agreement (BAA) gives Tool B an edge in enterprise readiness for software solutions.
Innovation
cV4 Diagnostic Ultrasound SystemTool A demonstrates a broader range of innovation, combining multiple AI-powered features for real-time assistance (HeartAssist, NerveTrack, BiometryAssist, LaborAssist) with a novel 'world's first fanless design' for the hardware. While Tool B's AI for predictive risk stratification is innovative, Tool A's innovation spans both advanced software algorithms and groundbreaking hardware engineering.
Support & Docs
TieThe provided structured facts do not contain specific information regarding the availability or quality of support and documentation for either Tool A or Tool B. Without further comparative details, it is not possible to definitively determine a winner in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | cV4 Diagnostic Ultrasound System | Tempus ECG-AF |
|---|---|---|
| Name | cV4 Diagnostic Ultrasound System | Tempus ECG-AF |
| Company | Samsung Medison Co. | Tempus AI, Inc. |
| Description Summary | AI-enabled, fanless diagnostic ultrasound system offering advanced imaging, streamlined workflows, and robust data security for diverse clinical applications. | FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months. |
| Primary AI Function | AI-powered assistance for fetal heart assessment, nerve detection, fetal measurements, and fetal angle of progression estimation. | AI-based algorithm for 12-lead ECG analysis to detect signs associated with new onset Atrial Fibrillation (AF) within 12 months. |
| Target Patient/Data | Diverse clinical applications; input is ultrasound data. | Patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery; input is 12-lead ECG recordings. |
Videos
Demos, reviews, and walkthroughs featuring cV4 Diagnostic Ultrasound System and Tempus ECG-AF.